UPADACITINIB AS MONOTHERAPY IN PATIENTS WITH RHEUMATOID ARTHRITIS AND PRIOR INADEQUATE RESPONSE TO METHOTREXATE: RESULTS AT 84 WEEKS FROM THE SELECT-MONOTHERAPY STUDY

被引：3

作者：

Smolen, J. S. ^{[1
]}

Emery, P. ^{[2
,3
]}

Rigby, W. ^{[4
]}

Tanaka, Y. ^{[5
]}

Vargas, J. Ignacio ^{[6
]}

Damjanov, N. ^{[7
]}

Jain, M. ^{[8
]}

Song, Y. ^{[9
]}

Khan, N. ^{[9
]}

Enejosa, J. J. ^{[9
]}

Cohen, S. B. ^{[10
]}

机构：

[1] Med Univ Vienna, Vienna, Austria

[2] Univ Leeds, Leeds, W Yorkshire, England

[3] NIHR Biomed Res Ctr, Leeds, W Yorkshire, England

[4] Dartmouth Coll, Hanover, NH 03755 USA

[5] Univ Occupat & Environm Hlth, Kitakyushu, Fukuoka, Japan

[6] Quantum Res, Puerto Varas, Chile

[7] Univ Belgrade, Inst Rheumatol, Sch Med, Belgrade, Serbia

[8] Great Lakes Clin Trials, Chicago, IL USA

[9] AbbVie Inc, N Chicago, IL USA

[10] Metroplex Clin Res Ctr, Dallas, TX USA

来源：

ANNALS OF THE RHEUMATIC DISEASES | 2020年 / 79卷

关键词：

D O I：

10.1136/annrheumdis-2020-eular.961

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

THU0213

引用

页码：327 / 328

页数：2

共 50 条

[21] UPADACITINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS AND INADEQUATE RESPONSE OR INTOLERANCE TO BIOLOGICAL DMARDS: RESULTS AT 60 WEEKS FROM THE SELECT-BEYOND STUDY [J].

Genovese, Mark C. ;

Combe, Bernard ;

Hall, Stephen ;

Rubbert-Roth, Andrea ;

Zhong, Sheng ;

Meerwein, Sebastian ;

Pangan, Aileen ;

Fleischmann, Roy .

ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 :360-361

[22] UPADACITINIB AS MONOTHERAPY: A PHASE 3 RANDOMIZED CONTROLLED DOUBLE-BLIND STUDY IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS AND INADEQUATE RESPONSE TO METHOTREXATE [J].

Smolen, J. S. ;

Cohen, S. ;

Emery, P. ;

Rigby, W. ;

Tanaka, Y. ;

Zhang, Y. ;

Friedman, A. ;

Othman, A. A. ;

Camp, H. S. ;

Pangan, A. L. .

JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2019, 25 :S52-S52

[23] Upadacitinib As Monotherapy: A Phase 3 Randomized Controlled Double-Blind Study in Patients with Active Rheumatoid Arthritis and Inadequate Response to Methotrexate [J].

Smolen, Josef S. ;

Cohen, Stanley ;

Emery, Paul ;

Rigby, William F. C. ;

Tanaka, Yoshiya ;

Zhang, Ying ;

Friedman, Alan ;

Othman, Ahmed A. ;

Camp, Heidi S. ;

Pangan, Aileen L. .

ARTHRITIS & RHEUMATOLOGY, 2018, 70

[24] UPADACITINIB AS MONOTHERAPY: A PHASE 3 RANDOMISED CONTROLLED DOUBLE-BLIND STUDY IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS AND INADEQUATE RESPONSE TO METHOTREXATE [J].

Smolen, J. S. ;

Cohen, S. ;

Emery, P. ;

Rigby, W. ;

Tanaka, Y. ;

Zhang, Y. ;

Friedman, A. ;

Othman, A. A. ;

Camp, H. S. ;

Pangan, A. L. .

RHEUMATOLOGY, 2019, 58

[25] UPADACITINIB AS MONOTHERAPY: A PHASE 3 RANDOMISED CONTROLLED DOUBLE-BLIND STUDY IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS AND INADEQUATE RESPONSE TO METHOTREXATE [J].

Smolen, J. ;

Cohen, S. ;

Emery, P. ;

Rigby, W. ;

Tanaka, Y. ;

Zhang, Y. ;

Friedman, A. ;

Othman, A. ;

Camp, H. ;

Pangan, A. .

ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 :67-68

[26] Upadacitinib monotherapy versus methotrexate monotherapy in methotrexate-naive Japanese patients with rheumatoid arthritis: a sub-analysis of the Phase 3 SELECT-EARLY study [J].

Takeuchi, Tsutomu ;

Rischmueller, Maureen ;

Blanco, Ricardo ;

Xavier, Ricardo M. ;

Ueki, Yukitaka ;

Atsumi, Tatsuya ;

Chen, Su ;

Friedman, Alan ;

Pangan, Aileen L. ;

Strand, Vibeke ;

van Vollenhoven, Ronald F. .

MODERN RHEUMATOLOGY, 2021, 31 (03) :534-542

[27] WHICH STRATEGIES IN RHEUMATOID ARTHRITIS PATIENT WITH INADEQUATE RESPONSE TO METHOTREXATE MONOTHERAPY: THE STRATEGE STUDY [J].

Flipo, R. -M. ;

Gaujoux-Viala, C. ;

Hudry, C. ;

Zinovieva, E. ;

Leutenegger, E. ;

Herman-Demars, H. .

ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 :109-109

[28] Current smoking predicts inadequate response to methotrexate monotherapy in rheumatoid arthritis patients naive to DMARDs Results from a retrospective cohort study [J].

Floris, Alberto ;

Perra, Daniela ;

Cangemi, Ignazio ;

Congia, Mattia ;

Chessa, Elisabetta ;

Angioni, Maria Maddalena ;

Mangoni, Arduino Aleksander ;

Erre, Gian Luca ;

Mathieu, Alessandro ;

Piga, Matteo ;

Cauli, Alberto .

MEDICINE, 2021, 100 (17) :E25481

[29] SUSTAINABILITY OF RESPONSE BETWEEN UPADACITINIB AND ADALIMUMAB AMONG PATIENTS WITH RHEUMATOID ARTHRITIS AND PRIOR INADEQUATE RESPONSE TO METHOTREXATE [J].

Nash, Peter ;

Kavanaugh, Arthur ;

Buch, Maya ;

Combe, Bernard ;

Bessette, Louis ;

Song, In-Ho ;

Song, Yanna ;

Suboticki, Jessica ;

Fleischmann, Roy .

INTERNAL MEDICINE JOURNAL, 2021, 51 :46-47

[30] Sustainability of Response Between Upadacitinib and Adalimumab Among Patients with Rheumatoid Arthritis and Prior Inadequate Response to Methotrexate [J].

Nash, Peter ;

Kavanaugh, Arthur ;

Buch, Maya ;

Combe, Bernard ;

Bessette, Louis ;

Song, In-Ho ;

Song, Yanna ;

Suboticki, Jessica ;

Fleischmann, Roy .

ARTHRITIS & RHEUMATOLOGY, 2020, 72

← 1 2 3 4 5 →